Acromegaly and pregnancy: a contemporary review
Carregando...
Citações na Scopus
37
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOSCIENTIFICA LTD
Autores
Citação
EUROPEAN JOURNAL OF ENDOCRINOLOGY, v.177, n.1, p.R1-R12, 2017
Resumo
Although fertility is frequently impaired in women with acromegaly, pregnancy is apparently becoming more common due to improvement in acromegaly treatment as well as in fertility therapy. As a result, several studies on pregnancy in patients with acromegaly have been published in recent years adding new and relevant information to the preexisting literature. Also, new GH assays with selective specificities and the knowledge of the expression of the various GH genes have allowed a better understanding of somatotrophic axis function during pregnancy. In this review, we show that pregnancy in women with acromegaly is generally safe, usually with tumoral and hormonal stability. Although the paucity of data limits evidence-based recommendations for preconception counseling and pregnancy surveillance, controlling tumor size and hormonal activity before pregnancy is highly recommended to ensure better outcomes, and surgical control should be attempted when feasible. Treatment interruption at pregnancy confirmation has also proven to be safe, as drugs are not formally allowed to be used during pregnancy. Drug exposure (somatostatin analogs) during early or whole pregnancy might increase the chance of a lower birth weight. Aggressive disease is uncommon and may urge individual decisions such as surgery or drug treatment during pregnancy or lactation.
Palavras-chave
Referências
- ABELOVE WA, 1954, J CLIN ENDOCR METAB, V14, P32
- Alsat E, 1997, AM J OBSTET GYNECOL, V177, P1526, DOI 10.1016/S0002-9378(97)70103-0
- ASA SL, 1982, ARCH PATHOL LAB MED, V106, P360
- Assal A, 2016, OBSTET MED, V9, P9, DOI 10.1177/1753495X15598699
- Atmaca A, 2006, EXP CLIN ENDOCR DIAB, V114, P135, DOI 10.1055/s-2005-873004
- Balinskaite V, 2017, ANN SURG, V266, P260, DOI 10.1097/SLA.0000000000001976
- Baumann GP, 2012, ENDOCR REV, V33, P155, DOI 10.1210/er.2011-1035
- Baumann GP, 2009, GROWTH HORM IGF RES, V19, P333, DOI 10.1016/j.ghir.2009.04.011
- BECKERS A, 1990, J CLIN ENDOCR METAB, V71, P725
- Boguszewski CL, 2003, J ENDOCRINOL INVEST, V26, P274
- Boulanger C, 2004, J ENDOCRINOL INVEST, V27, P465
- Brian SR, 2007, J CLIN ENDOCR METAB, V92, P3374, DOI 10.1210/jc.2007-0997
- Bronstein MD, 2011, NAT REV ENDOCRINOL, V7, P301, DOI 10.1038/nrendo.2011.38
- Caron P, 2011, ANN ENDOCRINOL-PARIS, V72, P282, DOI 10.1016/j.ando.2011.07.002
- CARON P, 1995, NEW ENGL J MED, V333, P601, DOI 10.1056/NEJM199508313330918
- Caron P, 2010, J CLIN ENDOCR METAB, V95, P4680, DOI 10.1210/jc.2009-2331
- Chellakooty M, 2004, J CLIN ENDOCR METAB, V89, P384, DOI 10.1210/jc.2003-030282
- CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1
- Cheng S, 2012, CLIN ENDOCRINOL, V76, P264, DOI 10.1111/j.1365-2265.2011.04180.x
- Cheng V, 2012, PITUITARY, V15, P59, DOI 10.1007/s11102-011-0330-3
- Clapp JF, 2004, AM J OBSTET GYNECOL, V190, P730, DOI 10.1016/j.ajog.2003.09.061
- Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631
- Clemmons DR, 2006, ENDOCRINOLOGY, P643
- Colao A, 1997, J CLIN ENDOCR METAB, V82, P2777, DOI 10.1210/jc.82.9.2777
- Cozzi R, 2006, EUR J ENDOCRINOL, V155, P279, DOI 10.1530/eje.1.02215
- de Menis E, 1999, J CLIN ENDOCR METAB, V84, P1489, DOI 10.1210/jc.84.4.1489
- DENOTO FM, 1981, NUCLEIC ACIDS RES, V9, P3719, DOI 10.1093/nar/9.15.3719
- Dias M, 2014, EUR J ENDOCRINOL, V170, P301, DOI 10.1530/EJE-13-0460
- Dias ML, 2013, GROWTH HORM IGF RES, V23, P13, DOI 10.1016/j.ghir.2012.11.001
- Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022
- Edo A E, 2010, West Afr J Med, V29, P120
- ERIKSSON L, 1989, BRIT J OBSTET GYNAEC, V96, P949, DOI 10.1111/j.1471-0528.1989.tb03352.x
- Fassnacht M, 2001, CLIN ENDOCRINOL, V55, P411, DOI 10.1046/j.1365-2265.2001.01304.x
- Fuglsang J, 2005, CLIN ENDOCRINOL, V62, P554, DOI 10.1111/j.1365-2265.2005.02257.x
- Giustina A, 2008, J ENDOCRINOL INVEST, V31, P919
- GONZALEZ JG, 1988, AM J MED, V85, P217, DOI 10.1016/0002-9343(88)90542-6
- GOODMAN HM, 1991, ENDOCRINOLOGY, V129, P1779
- Greene DN, 2015, AM J CLIN PATHOL, V144, P830, DOI 10.1309/AJCP7O7VAREDUYIJ
- Grynberg M, 2010, J CLIN ENDOCR METAB, V95, P4518, DOI 10.1210/jc.2009-2815
- Guven S, 2006, J MATERN-FETAL NEO M, V19, P69, DOI 10.1080/14767050500434021
- Hachmi LB, 2010, ANN ENDOCRINOL-PARIS, V71, P60, DOI 10.1016/j.ando.2009.10.002
- Haliloglu O, 2016, PITUITARY, V19, P391, DOI 10.1007/s11102-016-0717-2
- HENNEN G, 1985, INT J FERTIL, V30, P27
- Herman-Bonert V, 1998, J CLIN ENDOCR METAB, V83, P727, DOI 10.1210/jc.83.3.727
- Hierl T, 2000, CLIN ENDOCRINOL, V53, P262, DOI 10.1046/j.1365-2265.2000.01058.x
- Hisano Michi, 2006, Archives of Gynecology and Obstetrics, V274, P171, DOI 10.1007/s00404-005-0114-y
- HO KY, 1987, J CLIN ENDOCR METAB, V64, P51
- IGOUT A, 1995, GROWTH REGULAT, V5, P60
- Iwai H, 2005, ENDOCR J, V52, P413, DOI 10.1507/endocrj.52.413
- Junnila RK, 2015, ENDOCRIN METAB CLIN, V44, P27, DOI 10.1016/j.ecl.2014.10.003
- Kasuki L, 2012, ENDOCR J, V59, P313
- Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700
- Kintiraki E, 2015, HORM-INT J ENDOCRINO, V14, P211, DOI 10.14310/horm.2002.1582
- KUPERSMITH MJ, 1994, ANN INTERN MED, V121, P473
- LANDOLT AM, 1989, NEW ENGL J MED, V320, P671
- Lau SL, 2008, J ENDOCRINOL INVEST, V31, P255
- Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035
- Lima GAB, 2010, GROWTH HORM IGF RES, V20, P87, DOI 10.1016/j.ghir.2009.10.001
- LUNARDI P, 1991, INT J GYNECOL OBSTET, V34, P71, DOI 10.1016/0020-7292(91)90542-D
- MACCAGNAN P, 1995, J CLIN ENDOCR METAB, V80, P2190, DOI 10.1210/jc.80.7.2190
- MACLEOD JN, 1991, ENDOCRINOLOGY, V128, P1298
- Maffei P, 2010, CLIN ENDOCRINOL, V72, P668, DOI 10.1111/j.1365-2265.2009.03706.x
- Manolopoulou J, 2012, CLIN CHEM, V58, P1446, DOI 10.1373/clinchem.2012.188128
- Mikhail N, 2002, MAYO CLIN PROC, V77, P297
- Molitch ME, 2015, EUR J ENDOCRINOL, V172, pR205, DOI 10.1530/EJE-14-0848
- MONTINI M, 1990, J ENDOCRINOL INVEST, V13, P193
- Mozas J, 1999, INT J GYNECOL OBSTET, V65, P71, DOI 10.1016/S0020-7292(98)00221-5
- Naccache Deeb Daoud, 2011, J Med Case Rep, V5, P386, DOI 10.1186/1752-1947-5-386
- Neal J M, 2000, Endocr Pract, V6, P148
- Obuobie K, 2001, J CLIN ENDOCR METAB, V86, P2456, DOI 10.1210/jc.86.6.2456
- OHERLIHY C, 1980, IRISH J MED SCI, V149, P281, DOI 10.1007/BF02939155
- Okada Y, 1997, ENDOCR J, V44, P117, DOI 10.1507/endocrj.44.117
- Persechini ML, 2015, PITUITARY, V18, P461, DOI 10.1007/s11102-014-0596-3
- Phelan N, 2012, CLIN ENDOCRINOL, V76, P729, DOI 10.1111/j.1365-2265.2011.04277.x
- Qureshi A, 2006, J ASSIST REPROD GEN, V23, P439, DOI 10.1007/s10815-006-9077-6
- Sahli R, 2008, DEUT MED WOCHENSCHR, V133, P2328, DOI 10.1055/s-0028-1100923
- Sanchez R, 1999, MED CLIN-BARCELONA, V113, P198
- SCHEITHAUER BW, 1990, MAYO CLIN PROC, V65, P461
- Serri O, 2003, ENDOCRINOLOGIST, V13, P17
- Shimatsu A, 2010, ENDOCR J, V57, P551
- Suzumori N, 2010, CURR MED CHEM, V17, P3431
- Takano T, 2006, ENDOCR J, V53, P209, DOI 10.1507/endocrj.53.209
- Takeuchi K, 1999, OBSTET GYNECOL, V93, P848, DOI 10.1016/S0029-7844(98)00461-X
- van der Lely AJ, 2015, ENDOCRINE, V49, P769, DOI 10.1007/s12020-014-0508-3
- Verhaeghe J, 2000, CLIN ENDOCRINOL, V53, P645, DOI 10.1046/j.1365-2265.2000.01044.x
- Wiesli P, 2006, ACTA OBSTET GYN SCAN, V85, P900, DOI 10.1080/00016340600676532
- Wu ZD, 2003, J CLIN ENDOCR METAB, V88, P804, DOI 10.1210/jc.2002-020787
- Wu ZD, 2010, GROWTH HORM IGF RES, V20, P239, DOI 10.1016/j.ghir.2010.02.006
- Yang MJ, 2013, J CHIN MED ASSOC, V76, P635, DOI 10.1016/j.jcma.2013.07.004
- YAP AS, 1990, AM J OBSTET GYNECOL, V163, P477
- Yen SS, 1991, REPROD ENDOCRINOLOGY
- [Anonymous], 2016, OBSTET GYNECOLOGY, V127, P75, DOI [10.1097/AOG.0000000000001309, DOI 10.1097/AOG.0000000000001309]